HAUPPAUGE, N.Y.--(BUSINESS WIRE)--Interpharm Holdings, Inc. (Amex: IPA), a manufacturer and distributor of generic pharmaceutical products, reported record sales of $22.83 million and net income of $1.63 million for the quarter ended September 30, 2006. For the quarter ended September 30, 2005, Interpharm’s sales were $14.55 million and it incurred a net loss of ($0.45) million.
